Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2025-12-30 @ 12:25 PM
Study NCT ID:
NCT00263159
Status:
COMPLETED
Last Update Posted:
2007-12-28
First Post:
2005-12-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D001249', 'term': 'Asthma'}], 'ancestors': [{'id': 'D001982', 'term': 'Bronchial Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}, {'id': 'D008173', 'term': 'Lung Diseases, Obstructive'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012130', 'term': 'Respiratory Hypersensitivity'}, {'id': 'D006969', 'term': 'Hypersensitivity, Immediate'}, {'id': 'D006967', 'term': 'Hypersensitivity'}, {'id': 'D007154', 'term': 'Immune System Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D010593', 'term': 'Pharmaceutical Services'}], 'ancestors': [{'id': 'D006296', 'term': 'Health Services'}, {'id': 'D005159', 'term': 'Health Care Facilities Workforce and Services'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 221}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2006-01'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2007-12', 'completionDateStruct': {'date': '2006-10', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2007-12-19', 'studyFirstSubmitDate': '2005-12-06', 'studyFirstSubmitQcDate': '2005-12-06', 'lastUpdatePostDateStruct': {'date': '2007-12-28', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2005-12-07', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'The difference between study groups in the change of asthma control from baseline and follow-up visits', 'timeFrame': 'after 1, 3 and 6 months'}], 'secondaryOutcomes': [{'measure': 'Peak flow', 'timeFrame': 'after 3 and 6 months'}, {'measure': 'Knowledge of asthma and treatment', 'timeFrame': 'after 6 months'}, {'measure': 'Asthma quality of life questionnaire (AQLQ)', 'timeFrame': 'after 6 months'}, {'measure': 'Therapy adherence'}, {'measure': 'Inhalation techniques', 'timeFrame': 'after 6 months'}, {'measure': 'Smoking', 'timeFrame': 'after 6 months'}, {'measure': 'Asthma exacerbations', 'timeFrame': 'after 6 months'}, {'measure': 'General Practitioner (GP) visits, emergency room visits and hospitalisations'}, {'measure': 'Working days lost and school days lost'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'conditions': ['Asthma']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'http://www.ugent.be', 'label': 'Website of the University Ghent'}]}, 'descriptionModule': {'briefSummary': 'The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.', 'detailedDescription': 'The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no input from pharmacist) or intervention group (= with pharmaceutical care at baseline and follow-up visits over 6 months).'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '50 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients with persistent asthma\n* Asthma treatment for at least 12 months\n* Regular visitors of the participating community pharmacy\n\nExclusion Criteria:\n\n* Severe co-morbidity\n* \\> 10 pack-years smoking history\n* Asthma Control Test score \\< 15 or =25'}, 'identificationModule': {'nctId': 'NCT00263159', 'briefTitle': 'Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study', 'organization': {'class': 'OTHER', 'fullName': 'University Ghent'}, 'officialTitle': 'Pharmaceutical Care for Asthma Control Improvement', 'orgStudyIdInfo': {'id': '2005/320'}}, 'armsInterventionsModule': {'interventions': [{'name': 'Pharmaceutical care for asthma patients', 'type': 'PROCEDURE'}]}, 'contactsLocationsModule': {'locations': [{'zip': '9000', 'city': 'Ghent', 'country': 'Belgium', 'facility': 'University Hospital Ghent', 'geoPoint': {'lat': 51.05, 'lon': 3.71667}}], 'overallOfficials': [{'name': 'Guy Brusselle, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'University Hospital, Ghent'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University Ghent', 'class': 'OTHER'}}}}